ARCHIVES

Clearinghouse Says In Business

This article is from The Cancer Letter archive.

Vol. 05 No. 04 | January 26, 1979

Download PDF Visit The Full Archive

Related Articles

Cooperative Groups Woven Through Fabric Of NCI, Broder Says

June 10, 1994

Five-Year Course of Tamoxifen Remains Standard Treatment In HR+ Breast Cancer

July 26, 2002

“I Can’t Permit Destruction of NSABP,” Fisher Writes

September 9, 1994

Clinical Trials: Institutions Invited By NSABP To Join Raloxifene Trial

July 10, 1998

President, Congress Decry Practice Of “Drive-Through Mastectomies

February 21, 1997

Trastuzumab Showed Improved Survival In Stage IV Breast Cancer with CNS Metastases

August 26, 2011